Interfering with UDP-GlcNAc metabolism and heparan sulfate expression using a sugar analogue reduces angiogenesis

ACS Chemical Biology

Volumn 8, Issue 10, 2013, Pages 2331-2338

  Van Wijk, Xander M ^a   Thijssen, Victor L ^b   Lawrence, Roger ^c   Van Den Broek, Sebastiaan A ^d   Dona, Margo ^a,e   Naidu, Natasha ^d   Oosterhof, Arie ^a   Van De Westerlo, Els M ^a   Kusters, Lisanne J ^a   Khaled, Yasmine ^f   Jokela, Tiina A ^g   Nowak Sliwinska, Patrycja ^b,h   Kremer, Hannie ^a,f   Stringer, Sally E ⁱ   Griffioen, Arjan W ^b   Van Wijk, Erwin ^a,f   Van Delft, Floris L ^d   Van Kuppevelt, Toin H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^f RADBOUD UNIVERSITY   (Netherlands)

^g UNIVERSITY OF EASTERN FINLAND   (Finland)

^h EPFL   (Switzerland)

ⁱ UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 DEOXY N ACETYLGLUCOSAMINE; FIBROBLAST GROWTH FACTOR 2; GLYCOSAMINOGLYCAN; GLYCOSYLTRANSFERASE; HEPARAN SULFATE; N ACETYLGLUCOSAMINE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE N ACETYLGLUCOSAMINE; VASCULOTROPIN; IDURONIC ACID; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; BIOSYNTHESIS; CARBOHYDRATE METABOLISM; CARCINOGENESIS; CHEMICAL REACTION; CHEMICAL STRUCTURE; CHICKEN; CHORION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; MICROINJECTION; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ZEBRA FISH; ANALOGS AND DERIVATIVES; ANIMAL; ANIMAL EMBRYO; CHEMISTRY; DOWN REGULATION; DRUG EFFECTS; GENETICS; METABOLISM; PATHOPHYSIOLOGY;

DANIO RERIO;

ANIMALS; CHICKENS; DOWN-REGULATION; EMBRYO, NONMAMMALIAN; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION; HEPARITIN SULFATE; IDURONIC ACID; NEOVASCULARIZATION, PATHOLOGIC; SIGNAL TRANSDUCTION; URIDINE DIPHOSPHATE N-ACETYLGLUCOSAMINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; ZEBRAFISH;

EID: 84886569129     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb4004332     Document Type: Article

References (32)

1. Lindahl, U. and Li, J. P. (2009) Interactions between heparan sulfate and proteins-design and functional implications Int. Rev. Cell. Mol. Biol. 276, 105-159
2. Yayon, A., Klagsbrun, M., Esko, J. D., Leder, P., and Ornitz, D. M. (1991) Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor Cell 64, 841-848
3. Gitay-Goren, H., Soker, S., Vlodavsky, I., and Neufeld, G. (1992) The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules J. Biol. Chem. 267, 6093-6098
4. Sasisekharan, R., Shriver, Z., Venkataraman, G., and Narayanasami, U. (2002) Roles of heparan-sulphate glycosaminoglycans in cancer Nat. Rev. Cancer 2, 521-528
5. Esko, J. D. and Selleck, S. B. (2002) Order out of chaos: assembly of ligand binding sites in heparan sulfate Annu. Rev. Biochem. 71, 435-471
6. Chen, E., Stringer, S. E., Rusch, M. A., Selleck, S. B., and Ekker, S. C. (2005) A unique role for 6-O sulfation modification in zebrafish vascular development Dev. Biol. 284, 364-376
7. Ferreras, C., Rushton, G., Cole, C. L., Babur, M., Telfer, B. A., van Kuppevelt, T. H., Gardiner, J. M., Williams, K. J., Jayson, G. C., and Avizienyte, E. (2012) Endothelial heparan sulfate 6-O-sulfation levels regulate angiogenic responses of endothelial cells to fibroblast growth factor 2 and vascular endothelial growth factor J. Biol. Chem. 287, 36132-36146
8. Liu, D., Shriver, Z., Venkataraman, G., El Shabrawi, Y., and Sasisekharan, R. (2002) Tumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor growth and metastasis Proc. Natl. Acad. Sci. U.S.A. 99, 568-573
9. Parish, C. R., Freeman, C., Brown, K. J., Francis, D. J., and Cowden, W. B. (1999) Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity Cancer Res. 59, 3433-3441
10. Berkin, A., Szarek, M. A., Plenkiewicz, J., Szarek, W. A., and Kisilevsky, R. (2000) Synthesis of 4-deoxy analogues of 2-acetamido-2-deoxy-D- glucose and 2-acetamido-2-deoxy-D-xylose and their effects on glycoconjugate biosynthesis Carbohydr. Res. 325, 30-45
11. Berkin, A., Szarek, W. A., and Kisilevsky, R. (2000) Synthesis of 4-deoxy-4-fluoro analogues of 2-acetamido-2-deoxy-D-glucose and 2-acetamido-2-deoxy-D-galactose and their effects on cellular glycosaminoglycan biosynthesis Carbohydr. Res. 326, 250-263
12. Kisilevsky, R., Szarek, W. A., Ancsin, J. B., Elimova, E., Marone, S., Bhat, S., and Berkin, A. (2004) Inhibition of amyloid A amyloidogenesis in vivo and in tissue culture by 4-deoxy analogues of peracetylated 2-acetamido-2-deoxy- alpha- and beta-d-glucose: implications for the treatment of various amyloidoses Am. J. Pathol. 164, 2127-2137
13. Nigro, J., Wang, A., Mukhopadhyay, D., Lauer, M., Midura, R. J., Sackstein, R., and Hascall, V. C. (2009) Regulation of heparan sulfate and chondroitin sulfate glycosaminoglycan biosynthesis by 4-fluoro-glucosamine in murine airway smooth muscle cells J. Biol. Chem. 284, 16832-16839
14. van Wijk, X. M., Oosterhof, A., van den Broek, S. A., Griffioen, A. W., ten Dam, G. B., Rutjes, F. P., van Delft, F. L., and van Kuppevelt, T. H. (2010) A 4-deoxy analogue of N-acetyl-D-glucosamine inhibits heparan sulphate expression and growth factor binding in vitro Exp. Cell Res. 316, 2504-2512
15. Sarkar, A. K., Fritz, T. A., Taylor, W. H., and Esko, J. D. (1995) Disaccharide uptake and priming in animal cells: inhibition of sialyl Lewis X by acetylated Gal beta 1→4GlcNAc beta-O-naphthalenemethanol Proc. Natl. Acad. Sci. U.S.A. 92, 3323-3327
16. Bernacki, R. J., Sharma, M., Porter, N. K., Rustum, Y., Paul, B., and Korythyk, W. (1977) Biochemical characteristics, metabolism, and antitumor activity of several acetylated hexosamines J. Supramol. Struct. 7, 235-250
17. Barthel, S. R., Antonopoulos, A., Cedeno-Laurent, F., Schaffer, L., Hernandez, G., Patil, S. A., North, S. J., Dell, A., Matta, K. L., Neelamegham, S., Haslam, S. M., and Dimitroff, C. J. (2011) Peracetylated 4-fluoro-glucosamine reduces the content and repertoire of N- and O-glycans without direct incorporation J. Biol. Chem. 286, 21717-21731
18. Nishimura, S. I., Hato, M., Hyugaji, S., Feng, F., and Amano, M. (2012) Glycomics for drug discovery: Metabolic perturbation in androgen-independent prostate cancer cells induced by unnatural hexosamine mimics Angew. Chem., Int. Ed. 51, 3386-3390
19. Gloster, T. M., Zandberg, W. F., Heinonen, J. E., Shen, D. L., Deng, L., and Vocadlo, D. J. (2011) Hijacking a biosynthetic pathway yields a glycosyltransferase inhibitor within cells Nat. Chem. Biol. 7, 174-181
20. Zandberg, W. F., Kumarasamy, J., Pinto, B. M., and Vocadlo, D. J. (2012) Metabolic inhibition of sialyl-Lewis X biosynthesis by 5-thiofucose remodels the cell surface and impairs selectin-mediated cell adhesion J. Biol. Chem. 287, 40021-40030
21. Rillahan, C. D., Antonopoulos, A., Lefort, C. T., Sonon, R., Azadi, P., Ley, K., Dell, A., Haslam, S. M., and Paulson, J. C. (2012) Global metabolic inhibitors of sialyl- and fucosyltransferases remodel the glycome Nat. Chem. Biol. 8, 661-668
22. Dimitroff, C. J., Bernacki, R. J., and Sackstein, R. (2003) Glycosylation-dependent inhibition of cutaneous lymphocyte-associated antigen expression: implications in modulating lymphocyte migration to skin Blood 101, 602-610
23. Pouilly, S., Bourgeaux, V., Piller, F., and Piller, V. (2012) Evaluation of analogues of GalNAc as substrates for enzymes of the mammalian GalNAc salvage pathway ACS Chem. Biol. 7, 753-760
24. Kumarasuriyar, A., Lee, I., Nurcombe, V., and Cool, S. M. (2009) De-sulfation of MG-63 cell glycosaminoglycans delays in vitro osteogenesis, up-regulates cholesterol synthesis and disrupts cell cycle and the actin cytoskeleton J. Cell Physiol. 219, 572-583
25. Baskin, J. M., Dehnert, K. W., Laughlin, S. T., Amacher, S. L., and Bertozzi, C. R. (2010) Visualizing enveloping layer glycans during zebrafish early embryogenesis Proc. Natl. Acad. Sci. U.S.A. 107, 10360-10365
26. Lee, J. S., von der Hardt, S., Rusch, M. A., Stringer, S. E., Stickney, H. L., Talbot, W. S., Geisler, R., Nusslein-Volhard, C., Selleck, S. B., Chien, C. B., and Roehl, H. (2004) Axon sorting in the optic tract requires HSPG synthesis by ext2 (dackel) and extl3 (boxer) Neuron 44, 947-960
27. Bink, R. J., Habuchi, H., Lele, Z., Dolk, E., Joore, J., Rauch, G. J., Geisler, R., Wilson, S. W., den Hertog, J., Kimata, K., and Zivkovic, D. (2003) Heparan sulfate 6-o-sulfotransferase is essential for muscle development in zebrafish J. Biol. Chem. 278, 31118-31127
28. Serbedzija, G. N., Flynn, E., and Willett, C. E. (1999) Zebrafish angiogenesis: a new model for drug screening Angiogenesis 3, 353-359
29. Laughlin, S. T., Baskin, J. M., Amacher, S. L., and Bertozzi, C. R. (2008) In vivo imaging of membrane-associated glycans in developing zebrafish Science 320, 664-667
30. Ruhrberg, C., Gerhardt, H., Golding, M., Watson, R., Ioannidou, S., Fujisawa, H., Betsholtz, C., and Shima, D. T. (2002) Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis Genes Dev. 16, 2684-2698
31. Lawrence, R., Olson, S. K., Steele, R. E., Wang, L., Warrior, R., Cummings, R. D., and Esko, J. D. (2008) Evolutionary differences in glycosaminoglycan fine structure detected by quantitative glycan reductive isotope labeling J. Biol. Chem. 283, 33674-33684
32. Lammers, G., Gilissen, C., Nillesen, S. T., Uijtdewilligen, P. J., Wismans, R. G., Veltman, J. A., Daamen, W. F., and van Kuppevelt, T. H. (2010) High density gene expression microarrays and gene ontology analysis for identifying processes in implanted tissue engineering constructs Biomaterials 31, 8299-8312